Spain Neurovascular Devices Market (2025-2030)
The Spain Neurovascular Devices Market was valued at $87.01 Million in 2025 and projected to reach to $123.01 Million by 2030, representing a compound annual growth rate of 7.2%. Spain's neurovascular devices market is positioned for sustained growth through 2030, driven by an aging population with rising incidence of cerebrovascular diseases and stroke.
Spain Neurovascular Devices Market Trends and Insights
- Spain's healthcare infrastructure and aging population are driving demand for advanced neurovascular interventions, including stroke management and aneurysm treatment devices.
- The market in Spain benefits from strong regulatory frameworks and increasing adoption of minimally invasive procedures across Spanish hospitals and specialized centers. The growth trajectory in Spain reflects broader European trends toward precision medicine and interventional neurology.
- Spain's investment in healthcare technology and the rising prevalence of cerebrovascular diseases are key factors supporting market expansion through 2030.
- Healthcare providers in Spain are increasingly integrating cutting-edge neurovascular solutions to improve patient outcomes and reduce procedural complications..
Key Market Statistics
- CAGR (2025-2030) 7.2% CAGR
- Market Size, 2025 ~USD 87.01 Million
- Forecast, 2030 ~USD 123.01 Million
- Country Spain
Spain Neurovascular Devices Market Overview
Market Valuation Growth :
Spain's neurovascular devices market is valued at $87.01 million in 2025 and is projected to reach $123.01 million by 2030, demonstrating steady expansion at a 7.2% CAGR over the forecast period.
Aging Population Dynamics :
Spain's demographic shift toward an older population is significantly driving demand for neurovascular interventions, particularly for stroke management and age-related cerebrovascular conditions requiring advanced treatment devices.
Healthcare Infrastructure Strength :
Spain's robust healthcare system and well-established medical device regulatory framework support the adoption of innovative neurovascular technologies and facilitate market penetration by leading device manufacturers.
Clinical Application Focus :
The Spanish market is characterized by increasing utilization of neurovascular devices for stroke management, aneurysm treatment, and other cerebrovascular interventions, reflecting advanced clinical practice standards.
Spain Neurovascular Devices Market Dynamics
- The country's advanced healthcare infrastructure and strong regulatory environment create favorable conditions for device adoption and innovation.
- Healthcare providers in Spain are increasingly investing in minimally invasive neurovascular interventions, supporting market expansion.
- Government healthcare initiatives and reimbursement policies further support market development, while partnerships between Spanish hospitals and international device manufacturers enhance technology accessibility and clinical outcomes..
Related Ecosystem
Key Takeaways
- Spain's neurovascular devices market is projected to grow from $87.01M (2025) to $123.01M (2030) at a 7.2% CAGR.
- Spain's aging demographic and rising cerebrovascular disease prevalence are primary growth catalysts for neurovascular device adoption.
- Minimally invasive procedures are gaining traction in Spain, driving demand for advanced intervention technologies.
- Spain's robust healthcare regulatory environment supports market expansion and device innovation through 2030.
Neurovascular Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CLOT RETRIEVER DEVICES (Type 2023–2030) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.3% from 2025 to 2030 |
| Largest Segment | HOSPITALS AND AMBULATORY SURGICAL CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 4.7 (2025) |
| Revenue Forecast (Billions) | ~USD 7.33 (2030) |
| Segments Covered | Disease Pathology, Type, Type 2023–2030, End User |
Spain Neurovascular Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Disease Pathology
- Arteriovenous Malformations & Fistulas
- Arteriovenous Malformations And Fistulas
- Carotid Artery Stenosis
- Cerebral Aneurysms
- Device For Cerebral Aneurysms
- Ischemic Strokes
- Other Disease Pathologies
By Type
- Balloon Catheters
- Bare Detachable Coils
- Carotid Artery Stents
- Clot Retriever Devices
- Coated Detachable Coils
- Embolic Coils
- Embolic Protection Devices
- Flow Diversion Devices
- Intracranial Stents
- Liquid Embolic Agents
- Microcatheter
- Microcatheters
- Occlusion Balloon Catheters
- Other Devices
- Suction & Aspiration Devices
- Vascular Snares
By Type 2023–2030
- Balloon Catheters
- Clot Retriever Devices
- Other Devices
- Suction & Aspiration Devices
- Vascular Snares
By End User
- Hospitals And Ambulatory Surgical Centers
- Research And Academic Institutes
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Neurovascular device companies need Spain-specific market data to develop localized commercialization strategies, understand competitive positioning, and identify opportunities for product launches and market expansion in this growing European market.
- Healthcare Investors & PE Firms : Investment professionals require detailed Spain market analysis to evaluate acquisition targets, assess portfolio company growth potential, and make informed capital allocation decisions in the neurovascular devices sector.
- Hospital & Clinical Networks : Spanish healthcare institutions need market intelligence to benchmark device adoption rates, evaluate procurement strategies, and understand emerging treatment trends to optimize patient outcomes and operational efficiency.
- Market Research & Consulting Firms : Research organizations require comprehensive Spain market data to support client advisory services, competitive analysis, and strategic planning initiatives for healthcare and medical device industry stakeholders.
- Regulatory & Compliance Professionals : Regulatory specialists need Spain-specific market insights to navigate healthcare compliance requirements, understand reimbursement frameworks, and ensure successful device registration and market authorization in the Spanish healthcare system.
Key Companies in the Spain Neurovascular Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Software and digital solutions, |
| NOLATO | Sweden | Public Company | Medical components and systems (Medical Solutions),Pharmaceutical primary packaging and labware,EMC shielding and thermal management (Compatherm, Compashield, Trishield), |
| CONMED CORPORATION | United States | Public Company | Sports medicine & orthopedic arthroscopy (BioBrace, TruShot, Y-Knot, Agro, powered resection, fluid management, visualization),Hall large and small bone power tools,General surgery: AirSeal insufflation, Buffalo smoke evacuation, endomechanical (trocars, retrieval bags, suction-irrigation, graspers, scissors, dissectors), |
| LIVANOVA PLC | United Kingdom | Public Company | Cardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion disposables and services),Neuromodulation (VNS Therapy for epilepsy and depression, OSA development programs), |
| BIOGEN | United States | Public Company | Multiple sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS-related),SMA and rare neuromuscular (SPINRAZA, QALSODY),Alzheimer’s and neuropsychiatry (LEQEMBI, ZURZUVAE), |
| JOHNSON & JOHNSON | United States | Public Company | Oncology,Immunology,Neuroscience & Other Innovative Medicine, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| PENUMBRA, INC. | United States | Public Company | Neurovascular mechanical thrombectomy (Penumbra System, RED, JET, ACE, ENGINE, 3D Revascularization),Peripheral thrombectomy (Indigo, Lightning Flash, Lightning Bolt 7, CAT RX),Neuro embolization coils and POD/PAC platforms, |
| MICROPORT SCIENTIFIC CORPORATION | China | Public Company | Cardiovascular Devices (coronary stents, balloons, accessories),Orthopedics Devices (reconstructive joints, spine, trauma),Cardiac Rhythm Management (pacemakers, CRT, defibrillators), |
| KANEKA CORPORATION | Japan | Public Company | PVC and Vinyl Polymers (PVC, crosslinked PVC, PVC-PVAc, paste PVC, chlorinated PVC),Specialty Additives and Engineering Resins (impact modifiers, processing aids, tougheners, engineering resin for injection molding),High-Performance Films and Thermal Materials (polyimide film, optical films, graphite sheets, multi-layer insulation), |
| ASAHI INTECC CO., LTD | Japan | Public Company | PCI guide wires and cardiology catheters,Peripheral and cerebrovascular guide wires and microcatheters,Angiography and general-purpose catheters, |
| JAPAN LIFELINE CO., LTD | Japan | Public Company | Electrophysiology and Ablation Products,Cardiac Rhythm Management and Defibrillation,Cardiovascular and Endografting, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems for manufacturing industries.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company operates in the manufacturing and materials processing sectors.
CONMED CORPORATION
CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company operates in the medical device and healthcare equipment industry.
LIVANOVA PLC
LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees. The company specializes in medical devices and healthcare solutions.
BIOGEN
Biogen is a United States-based public company founded in 1978 with 7,500 employees. The company specializes in biotechnology and biopharmaceutical development.
JOHNSON & JOHNSON
Johnson & Johnson is a United States-based public company founded in 1886 with 138,200 employees. The company is a diversified healthcare conglomerate operating in pharmaceuticals, medical devices, and consumer health.
TERUMO CORPORATION
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company specializes in medical devices and healthcare products.
PENUMBRA, INC.
Penumbra, Inc. is a United States-based public company founded in 2004 with 4,700 employees. The company develops and manufactures medical devices for vascular and neurovascular interventions.
MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific Corporation is a Chinese public company founded in 1998 with 6,547 employees. The company specializes in medical device manufacturing and cardiovascular solutions.
KANEKA CORPORATION
Kaneka Corporation is a Japanese public company founded in 1949 with 11,762 employees. The company operates in chemicals, plastics, and medical device manufacturing.
ASAHI INTECC CO., LTD
Asahi Intecc Co., Ltd is a Japanese public company founded in 1976 with 9,473 employees. The company specializes in medical devices and interventional equipment.
JAPAN LIFELINE CO., LTD
Japan Lifeline Co., Ltd is a Japanese public company founded in 1981 with 1,304 employees. The company operates in the medical device and healthcare industry.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Spain's neurovascular market ($87.01M in 2025) with verified 7.2% CAGR projections through 2030, enabling accurate financial forecasting and investment decisions specific to the Spanish market.
- Competitive Landscape Intelligence : Understand Spain-specific competitive dynamics, key market players, and their positioning within the neurovascular devices sector to identify partnership opportunities and market entry strategies tailored to Spanish healthcare providers.
- Regulatory & Reimbursement Insights : Access detailed analysis of Spain's healthcare regulatory environment, reimbursement policies, and compliance requirements for neurovascular devices, reducing market entry risks and accelerating commercialization timelines.
- Clinical Demand Drivers : Leverage Spain-specific epidemiological data on stroke incidence, aneurysm prevalence, and aging demographics to understand clinical demand drivers and tailor product development and marketing strategies accordingly.
- Strategic Market Expansion : Identify growth opportunities within Spain's healthcare system, including hospital networks, interventional centers, and emerging clinical applications for neurovascular devices to optimize market penetration and revenue growth.
Frequently asked questions
What is the current size of Spain's neurovascular devices market?
Spain's neurovascular devices market is valued at $87.01 million in 2025.
What is the projected market size for Spain by 2030?
Spain's neurovascular devices market is forecast to reach $123.01 million by 2030.
What is the growth rate for Spain's neurovascular devices market?
Spain's neurovascular devices market is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2030.
What factors are driving growth in Spain's neurovascular devices market?
Key drivers include Spain's aging population, rising prevalence of cerebrovascular diseases, increased adoption of minimally invasive procedures, and strong healthcare infrastructure investment.
Which neurovascular device segments are most relevant in Spain?
Spain's market includes stroke management devices, aneurysm treatment solutions, and other interventional neurology technologies supported by advanced hospital networks.
RESEARCH METHODOLOGY
The study included four main activities to estimate the current size of the neurovascular devices market. First, extensive secondary research was performed to collect information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. We used both top-down and bottom-up approaches to develop a comprehensive estimate of the overall market size. Finally, we applied market segmentation and data triangulation techniques to assess the sizes of segments and subsegments within the market.
Secondary Research
The secondary research process involved extensively using various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research aimed to gather information valuable for a thorough, technical, market-focused, and commercial study of the neurovascular devices market. It also helped obtain key insights about industry leaders, market classification, and segmentation based on current industry trends, down to the smallest details. Additionally, a database of leading industry players was compiled through this secondary research.
Primary Research
In the primary research process, we conducted interviews with various sources from both the supply and demand sides to collect qualitative and quantitative information for this report. On the supply side, we spoke with industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the neurovascular devices market. For the demand side, we engaged with industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research was crucial to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents for the neurovascular devices market is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the neurovascular devices market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the neurovascular devices market was determined from annual presentations by leading players and secondary data available in the public domain. The share of products and services within the overall neurovascular devices market was derived from secondary data and validated by primary participants to estimate the total market. Primary participants further confirmed the validity of these data numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each stage, the assumptions and approaches were verified through industry experts contacted during primary research. Given the limitations of data available from secondary research, revenue estimates for individual companies—covering the overall neurovascular devices market and regional market assessments—were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.
Global Neurovascular Devices Market Size: Bottom-Up and Top-Down Approach
Data Triangulation
After determining the overall size from the market size estimation process described above, the total market was divided into multiple segments and subsegments. The data triangulation and market breakdown procedures explained below were applied, where applicable, to complete the overall market analysis and derive precise statistics for various market segments and subsegments. The data was triangulated by examining diverse factors and trends from both the demand and supply sides. Additionally, the market size was validated using both top-down and bottom-up methods.
Market Definition
The neurovascular devices market includes medical technologies and tools designed for monitoring, managing, and treating neurovascular diseases. It encompasses devices used to treat brain aneurysms (such as embolic coils, flow diversion devices, intracranial stents, and others), ischemic strokes (like clot retriever devices, suction and aspiration tools, vascular snares, balloon catheters, and more), carotid artery stenosis (including carotid artery stents, embolic protection devices, and balloon catheters), arteriovenous malformations and fistulas (such as liquid embolic agents, occlusion balloon catheters, microcatheters), and other related conditions. Neurovascular devices are essential for accurate diagnosis, effective treatment, and comprehensive management of neurovascular disorders. By enabling timely interventions and enhancing procedural success, these technologies help reduce complications and promote better patient recovery. The market serves patients, healthcare professionals, and medical institutions, driven by continuous advancements in device technology, the rising prevalence of neurovascular disorders, and increasing demand for innovative, minimally invasive, and user-friendly treatment options.
Stakeholders
- Neurovascular devices’ manufacturing companies
- Contract manufacturers
- Distributors, suppliers, and channel partners of neurovascular devices
- Senior Management
- Finance Department
- Procurement Department
- Hospitals & Clinics
- E-commerce and Digital Platforms
- Academic & Research Institutes
- Trade Associations and Industry Bodies
- Regulatory Bodies and Government Agencies
- Business Research and Consulting Service Providers
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, segment, analyse, and forecast the global neurovascular devices market by disease pathology, end user, and region
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the neurovascular devices market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To profile the key players in the neurovascular devices market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the neurovascular devices market
Get the Full Neurovascular Devices Market Report
Full forecast, segment splits, and company analysis for all Neurovascular Devices Market.
- Canada Neurovascular Devices Market
- US Neurovascular Devices Market
- Germany Neurovascular Devices Market
- France Neurovascular Devices Market
- UK Neurovascular Devices Market
- Italy Neurovascular Devices Market
- Japan Neurovascular Devices Market
- China Neurovascular Devices Market
- India Neurovascular Devices Market
- Australia Neurovascular Devices Market
- South Korea Neurovascular Devices Market
- Brazil Neurovascular Devices Market
- Mexico Neurovascular Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report